ArticleIndian journal of surgical oncology2025
Translation and Linguistic Validation of BIS (Body Image Scale) for Breast Cancer Patients in India.
Article in Indian journal of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Exploring Body Image Satisfaction in Post-Mastectomy Female Breast Cancer Patients.European journal of breast health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A number of PROMs (patient-reported outcome measures) have been developed and validated for English-speaking populations but with limited utility in non-English-speaking countries. Body image scale (BIS) is a type of PROM which assesses the changes in the body image of a patient diagnosed with cancer. The current study was carried out to translate the BIS in Hindi and Marathi. Out of the 10 questions in the BIS questionnaire, Hindi and Marathi translations were already available for 4 questions (Questions no. 2, 4, 5, and 9) from the EORTC BR23 questionnaire. Remaining questions were translated using the EORTC translation manual, which includes forward translation, reconciliation, backward translation, proofreading, and pilot testing. Pilot testing done on 10 patients each for Hindi and Marathi showed at least 80% acceptability for all the questions for both Hindi and Marathi translations. Both the translated versions will be used for validation in a large cohort of breast cancer patients. The Hindi and Marathi versions of the BIS have very good acceptability and can be utilized for clinical trials once validated in cancer patients. Supplementary Information: The online version contains supplementary material available at 10.1007/s13193-024-02037-2.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.